In this study, we have shown that BC cases with AR/ER ratio ≥ 2 (assessed by IHC and qPCR) are characterized by an increased proliferation status defined by a pooled gene expression analysis of AURKA, BIRC5, CCNB1, MKI67 and UBE2C proliferation markers. The gene discussed is AR; the disease is breast cancer.